Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.390
+0.010 (0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Employees
As of December 31, 2023, Acumen Pharmaceuticals had 52 total employees, including 51 full-time and 1 part-time employees. The number of employees increased by 12 or 30.00% compared to the previous year.
Employees
52
Change (1Y)
12
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,570,615
Market Cap
83.51M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52 | 12 | 30.00% |
Dec 31, 2022 | 40 | 23 | 135.29% |
Dec 31, 2021 | 17 | 10 | 142.86% |
Dec 31, 2020 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ABOS News
- 3 months ago - Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire
- 3 months ago - Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference - GlobeNewsWire
- 3 months ago - Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference - GlobeNewsWire
- 4 months ago - Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference - GlobeNewsWire
- 4 months ago - Lucy Therapeutics Appoints Kim Drapkin as Board Chair - Business Wire
- 5 months ago - Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - GlobeNewsWire